Spectroscopic methods for the detection of glycated hemoglobin
First Claim
Patent Images
1. A microfluidics device for determining a ratio of glycated hemoglobin to total hemoglobin, the microfluidics device comprising:
- a first compartment configured to receive a whole blood sample, the first compartment comprising a blood separation membrane and a waste collection material positioned therebelow and associated therewith, wherein the blood separation membrane traps red blood cells thereon and/or therein, and wherein plasma passes through the blood separation membrane and is wicked away from the blood separation membrane and into the waste collection material;
a second compartment comprising a negatively charged surface and a waste collection material positioned therebelow and associated therewith, wherein the negatively charged surface traps hemoglobin thereon and/or therein, and wherein other components of lysed red blood cells are not trapped on the negatively charged surface and are wicked away from the negatively charged surface and into the waste collection material, and wherein the negatively charged surface is configured for subjection to spectroscopy to measure an amount of total hemoglobin trapped thereon and/or therein and an amount of glycated hemoglobin or non-glycated hemoglobin trapped thereon and/or therein; and
an optical read chamber configured for optical interrogation by a spectrometer;
wherein the blood separation membrane is configured for releasable movement from association with the waste collection material to association with the negatively charged surface in the second compartment;
wherein the negatively charged surface is configured for releasable movement from association with the blood separation membrane to a position within the optical read chamber, and wherein the negatively charged surface can be subjected to spectroscopy within the optical read chamber for measuring (1) an amount of total hemoglobin present on the negatively charged surface, and (2) an amount of one of glycated hemoglobin or non-glycated hemoglobin present on the negatively charged surface; and
wherein a labeling agent is associated with or applied to one of the blood separation membrane and the negatively charged surface, wherein the labeling agent is configured to label one of glycated hemoglobin or non-glycated hemoglobin for measurement thereof.
1 Assignment
0 Petitions
Accused Products
Abstract
Kits, microfluidics devices, and assays for use in methods of spectroscopically determining a ratio of glycated hemoglobin to total hemoglobin in a whole blood sample are disclosed.
21 Citations
7 Claims
-
1. A microfluidics device for determining a ratio of glycated hemoglobin to total hemoglobin, the microfluidics device comprising:
-
a first compartment configured to receive a whole blood sample, the first compartment comprising a blood separation membrane and a waste collection material positioned therebelow and associated therewith, wherein the blood separation membrane traps red blood cells thereon and/or therein, and wherein plasma passes through the blood separation membrane and is wicked away from the blood separation membrane and into the waste collection material; a second compartment comprising a negatively charged surface and a waste collection material positioned therebelow and associated therewith, wherein the negatively charged surface traps hemoglobin thereon and/or therein, and wherein other components of lysed red blood cells are not trapped on the negatively charged surface and are wicked away from the negatively charged surface and into the waste collection material, and wherein the negatively charged surface is configured for subjection to spectroscopy to measure an amount of total hemoglobin trapped thereon and/or therein and an amount of glycated hemoglobin or non-glycated hemoglobin trapped thereon and/or therein; and an optical read chamber configured for optical interrogation by a spectrometer; wherein the blood separation membrane is configured for releasable movement from association with the waste collection material to association with the negatively charged surface in the second compartment; wherein the negatively charged surface is configured for releasable movement from association with the blood separation membrane to a position within the optical read chamber, and wherein the negatively charged surface can be subjected to spectroscopy within the optical read chamber for measuring (1) an amount of total hemoglobin present on the negatively charged surface, and (2) an amount of one of glycated hemoglobin or non-glycated hemoglobin present on the negatively charged surface; and wherein a labeling agent is associated with or applied to one of the blood separation membrane and the negatively charged surface, wherein the labeling agent is configured to label one of glycated hemoglobin or non-glycated hemoglobin for measurement thereof. - View Dependent Claims (2, 3, 4)
-
-
5. A method of determining a ratio of glycated hemoglobin to total hemoglobin in a whole blood sample, the method comprising the steps of:
-
applying a whole blood sample on an upper surface of a blood separation membrane of a microfluidics device, the blood separation membrane having a lower surface that is associated with a first waste collection material, whereby red blood cells in the whole blood sample are captured on and/or in the blood separation membrane while plasma passes through the blood separation membrane and is wicked away from the blood separation membrane and into the first waste collection material; moving a portion of the microfluidics device so that the blood separation membrane is positioned over a negatively charged surface having a second waste collection material positioned therebelow and in association therewith; applying a lysing agent to the blood separation membrane to lyse the red blood cells captured on and/or in the blood separation membrane and form lysed red blood cells, wherein the lysed red blood cells pass through the blood separation membrane and are brought into contact with the negatively charged surface, and wherein the negatively charged surface traps hemoglobin thereon and/or therein while other components of the lysed red blood cells are wicked away from the negatively charged surface and into the second waste collection material, wherein a labeling agent is associated with or applied to one of the blood separation membrane and the negatively charged surface, wherein the labeling agent is configured to label one of glycated hemoglobin or non-glycated hemoglobin for measurement thereof; moving a portion of the microfluidics device so that the negatively charged surface is positioned within an optical read chamber that allows for optical interrogation of the negatively charged surface by a spectrometer; spectroscopically measuring an amount of total hemoglobin on and/or in the negatively charged surface and an amount of one of glycated hemoglobin or non-glycated hemoglobin on and/or in the negatively charged surface; and determining a ratio of glycated hemoglobin to total hemoglobin in the whole blood sample based on the spectroscopic measurements. - View Dependent Claims (6, 7)
-
Specification